Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID: FREDUN
  • BSEID: 539730
INR
1,693.30
-14.4 (-0.84%)
BSENSE

Nov 20

BSE+NSE Vol: 10.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,693.30",
    "chg": -14.4,
    "chgp": "-0.84%",
    "dir": -1,
    "prev_price": "1,707.70",
    "mcapval": "2,851.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "FREDUN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE194R01017",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "10.42 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Gains 12.79%: 5 Key Factors Driving the Surge",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-gains-1279-5-key-factors-driving-the-surge-4270405",
        "imagepath": "",
        "date": "2026-11-21 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at Rs.1,487.35, down 0.93% amid flat Sensex</p>\n                    <p><strong>17 Nov:</strong> Sharp rebound with 5.80% gain to Rs.1,573.55</p>\n                    <p><strong>19 Nov:</strong> New 52-week and all-time high at Rs.1,680.65</p>\n                    <p><strong>20 Nov:</strong> Hits fresh 52-week and all-time high at Rs.1,730.80 before closing at Rs.1,693.30</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,501.25</div>\n                    </div>\n                   ..."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,730.8 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs-173080-4269024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/FredunPharmaceu_priceRelatedfactors_4269024.png",
        "date": "2026-11-20 09:34:14",
        "description": "Extending its winning streak to four consecutive sessions, Fredun Pharmaceuticals Ltd touched a fresh all-time high of Rs 1,730.8 on 20 Nov 2026, marking a remarkable rally of over 15% in just four days. This surge comes amid sustained outperformance against the broader Sensex and its sector peers, reflecting strong investor enthusiasm despite a minor dip of 0.28% on the day."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Indicator Shifts",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-sees-bullish-momentum-amid-technical-indicator-shifts-4268808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/FredunPharmaceu_technicaldot_4268808.png",
        "date": "2026-11-20 08:04:14",
        "description": "Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of technical indicator upgrades that signal renewed bullish sentiment. The micro-cap pharmaceutical company’s shares surged 4.49% today, closing at ₹1,707.70, just shy of its 52-week high of ₹1,712.00, reflecting strong investor interest amid evolving market dynamics."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1680.65 as Momentum Builds Across Timeframes",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs168065-marking-a-milestone-4267809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/FredunPharmaceu_priceRelatedfactors_4267809.png",
        "date": "2026-11-19 09:35:46",
        "description": ""
      },
      {
        "title": "Fredun Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-4259930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/FredunPharmaceu_valuationdot_4259930.png",
        "date": "2026-11-13 08:01:25",
        "description": "Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-4257831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/FredunPharmaceu_mojoScore_4257831.png",
        "date": "2026-11-11 10:10:52",
        "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 October 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 11 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Gains 7.88%: 2 Key Factors Driving the Weekly Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-gains-788-2-key-factors-driving-the-weekly-rally-4255271",
        "imagepath": "",
        "date": "2026-11-07 14:00:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Technical momentum shift noted amid mixed indicator signals</p>\n                    <p><strong>Nov 3:</strong> Continued price gains supported by positive market sentiment</p>\n                    <p><strong>Nov 4:</strong> Stock hits weekly high of Rs.1,509.60 (+3.76%)</p>\n                    <p><strong>Nov 5:</strong> Q2 FY27 results announced with 97% profit surge</p>\n                    <p><strong>Nov 6:</strong> Week closes at Rs.1,473.70 (-1.32%) after profit-taking</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                     ..."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-4245400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/FredunPharmaceu_mojoScore_4245400.png",
        "date": "2026-10-31 10:10:24",
        "description": "Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4240098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/FredunPharmaceu_technicaldot_4240098.png",
        "date": "2026-10-27 08:05:46",
        "description": "Fredun Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by mixed but increasingly positive signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a strengthening price momentum despite recent minor price fluctuations."
      }
    ],
    "total": 116,
    "sid": "1002605",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-Nov-2026",
      "details": "Transcript of the Earnings conference call held on 16th November 2026 for Q2 H1 FY 2027.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "16-Nov-2026",
      "details": "Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Dated 14.11.2026",
      "datetime": "14-Nov-2026",
      "details": "Outcome of the Board Meeting of Fredun Pharmaceuticals Limited (Company) pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26",
          "dt": "2026-06-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 16 Jul 26",
          "dt": "2026-07-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

19-Nov-2026 | Source : BSE

Transcript of the Earnings conference call held on 16th November 2026 for Q2 H1 FY 2027.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

16-Nov-2026 | Source : BSE

Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited.

Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Dated 14.11.2026

14-Nov-2026 | Source : BSE

Outcome of the Board Meeting of Fredun Pharmaceuticals Limited (Company) pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Fredun Pharmaceuticals Ltd has announced 2:1 bonus issue, ex-date: 16 Jul 26

stock-summary
RIGHTS

No Rights history available